TCL Archive Rejecting Data, Believers In PSA Screening Strengthen Guidelines, Launch Outreach September 11, 2009
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
